CANTON, Conn., March 17, 2025 /PRNewswire/ — Kelyniam Global (OTC:KLYG), a manufacturer of custom cranial implants, has announced its financial results for the year ended December 31, 2024. “Kelyniam had an exceptionally strong year in 2024,” stated Ross Bjella, Kelyniam’s CEO. “This…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.